glp-1 drugs news Compound versions of for weight loss halted by FDA GLP-1 Drugs Drop More Than
Description
Once daily injectable liraglutide (marketed as Victoza for T2DM and Saxenda for obesity) and once weekly injectable semaglutide (marketed as Ozempic for T2DM and Wegovy for obesity) are two additional GLP-1 analogues, sharing 97% and 94% amino acid homology to GLP-1, respectively [ Figure 2 , Table 1 ]
Data availability Data availability statement: This population-based study obtained data from the TrinetX platform (accessible at for which third-party restrictions apply to the availability of this data
The Wegovy injection pen has a needle already built-in to the device, while the Ozempic pen comes with needles to be attached
The drug works by mimicking the natural hormone amylin involved in increasing the time it takes for food to leave the stomach
[DOI] [PMC free article] [PubMed] [Google Scholar] 18.McInnes IB, Schett G
Nutritional support could come from: a dietician GP formalised online nutrition programs such as Noom or MyFitnessPal
